117 related articles for article (PubMed ID: 24816352)
21. Specialized compounding in community pharmacies: organizational perspective.
Giam JA; McLachlan AJ; Krass I
J Am Pharm Assoc (2003); 2010; 50(3):354-61. PubMed ID: 20452908
[TBL] [Abstract][Full Text] [Related]
22. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
Paudyal V; Hansford D; Cunningham S; Stewart D
Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
[TBL] [Abstract][Full Text] [Related]
23. HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection.
Weidle PJ; Lecher S; Botts LW; Jones L; Spach DH; Alvarez J; Jones R; Thomas V
J Am Pharm Assoc (2003); 2014; 54(5):486-92. PubMed ID: 25216878
[TBL] [Abstract][Full Text] [Related]
24. Chlamydia screening by community pharmacists: a qualitative study.
Dabrera G; Pinson D; Whiteman S
J Fam Plann Reprod Health Care; 2011 Jan; 37(1):17-21. PubMed ID: 21367698
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of community pharmacists' experiences with cholesterol screening programs.
Jungnickel PW; Wisehart DA
J Am Pharm Assoc (Wash); 1997; NS37(6):640-6. PubMed ID: 9425793
[TBL] [Abstract][Full Text] [Related]
26. Over-the-counter prescribing and pharmacists' adoption of new medicines: diffusion of innovations.
Paudyal V; Hansford D; Cunningham S; Stewart D
Res Social Adm Pharm; 2013; 9(3):251-62. PubMed ID: 22835710
[TBL] [Abstract][Full Text] [Related]
27. Exploring relationships among pharmacy service use, patronage motives, and patient satisfaction.
Patterson BJ; Doucette WR; Urmie JM; McDonough RP
J Am Pharm Assoc (2003); 2013; 53(4):382-9. PubMed ID: 23892811
[TBL] [Abstract][Full Text] [Related]
28. Virtualized healthcare delivery: understanding users and their usage patterns of online medical consultations.
Jung C; Padman R
Int J Med Inform; 2014 Dec; 83(12):901-14. PubMed ID: 25193501
[TBL] [Abstract][Full Text] [Related]
29. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
Mandt I; Horn AM; Ekedahl A; Granas AG
Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
[TBL] [Abstract][Full Text] [Related]
30. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.
Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K
J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931
[TBL] [Abstract][Full Text] [Related]
31. Pharmaceutical care in community pharmacies: practice and research in Sweden.
Westerlund LT; Björk HT
Ann Pharmacother; 2006 Jun; 40(6):1162-9. PubMed ID: 16735653
[TBL] [Abstract][Full Text] [Related]
32. Pharmacy patronage: identifying key factors in the decision making process using the determinant attribute approach.
Franic DM; Haddock SM; Tucker LT; Wooten N
J Am Pharm Assoc (2003); 2008; 48(1):71-85. PubMed ID: 18192134
[TBL] [Abstract][Full Text] [Related]
33. Pharmacists' perspectives on HIV testing in community pharmacies.
Ryder PT; Meyerson BE; Coy KC; von Hippel CD
J Am Pharm Assoc (2003); 2013; 53(6):595-600. PubMed ID: 24091415
[TBL] [Abstract][Full Text] [Related]
34. The decision to adopt evidence-based and other innovative mental health practices: risky business?
Panzano PC; Roth D
Psychiatr Serv; 2006 Aug; 57(8):1153-61. PubMed ID: 16870967
[TBL] [Abstract][Full Text] [Related]
35. Future-proofing the pharmacy profession in a hypercompetitive market.
Singleton JA; Nissen LM
Res Social Adm Pharm; 2014; 10(2):459-68. PubMed ID: 23820045
[TBL] [Abstract][Full Text] [Related]
36. Pharmaceutical care in community pharmacies: practice and research in Canada.
Jones EJ; Mackinnon NJ; Tsuyuki RT
Ann Pharmacother; 2005 Sep; 39(9):1527-33. PubMed ID: 16014374
[TBL] [Abstract][Full Text] [Related]
37. Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation.
Wells KM; Thornley T; Boyd MJ; Boardman HF
Res Social Adm Pharm; 2014; 10(1):58-71. PubMed ID: 23608701
[TBL] [Abstract][Full Text] [Related]
38. A qualitative exploration of opinions on the community pharmacists' role amongst the general public in Scotland.
Gidman W; Cowley J
Int J Pharm Pract; 2013 Oct; 21(5):288-96. PubMed ID: 23418884
[TBL] [Abstract][Full Text] [Related]
39. Perceptions of patients on Medicare Part D medication therapy management services.
Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
[TBL] [Abstract][Full Text] [Related]
40. Osteoporosis risk screening for women in a community pharmacy.
Liu Y; Nevins JC; Carruthers KM; Doucette WR; McDonough RP; Pan X
J Am Pharm Assoc (2003); 2007; 47(4):521-6. PubMed ID: 17616501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
